Bill Snyder

April 26, 2024

Vanderbilt’s Innovation Ambassadors help their colleagues change the world

Within the intellectual powerhouse that is Vanderbilt University and Vanderbilt University Medical Center thrives a group of doctors, engineers, computer scientists and others who also are visionaries, inventors and entrepreneurs. 

By Bill Snyder
Discovery Lecturer Vanessa Northington Gamble, MD, PhD, is an internationally known advocate for equity and justice in medicine and public health. (photo by Susan Urmy)
April 26, 2024

Discovery lecturer examines race and racism in health care

At her recent Discovery Lecture, Vanessa Northington Gamble, MD, PhD, described the deeply flawed yet lingering concept in American medicine that ascribes racial disparities in health status to inherent biological differences, rather than to environmental and sociological factors.

By Bill Snyder
April 25, 2024

Advance in the treatment of acute heart failure identified

A multicenter study led by Vanderbilt University Medical Center and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death.

By Bill Snyder
Diane Nash left, with Dorris Powell-Alexander, MD.
April 23, 2024

Civil Rights leader visits VUH Emergency Department

Legendary civil rights activist Diane Nash visited the emergency department at Vanderbilt University Medical Center on April 20 to acknowledge the naming of a physician team in her honor. 

By Bill Snyder
Julie Bastarache, MD (photo by Donn Jones)
April 22, 2024

Julie Bastarache elected VP of clinical investigation society

Julie Bastarache, MD, Assistant Vice President for Clinical & Translational Scientist Development at Vanderbilt University Medical Center, has been elected vice president of the American Society for Clinical Investigation (ASCI) for 2024-2025.

By Bill Snyder
Jeffrey Rathmell, PhD, and Melissa Wolf, PhD. (photo by Susan Urmy)
April 22, 2024

Study reveals potential new way to stop a common kidney cancer

Vanderbilt researchers have identified cancer cell-specific genetic alterations that reprogram the immune “landscape,” thereby driving tumor growth, and discovered a potential new drug target for stopping it.

By Bill Snyder
April 17, 2024

Common AFib drug linked to higher bleeding risk 

In a national retrospective study led by researchers at Vanderbilt University School of Medicine, diltiazem, when given in combination with the anticoagulant drugs apixaban (Eliquis) or rivaroxaban (Xarelto), significantly increased the risk of serious bleeding compared to metoprolol.
By Bill Snyder
April 9, 2024

Heart disease, depression linked by inflammation: study

Coronary artery disease and major depression may be genetically linked via inflammatory pathways to an increased risk for cardiomyopathy, a degenerative heart muscle disease, researchers at Vanderbilt University Medical Center and Massachusetts General Hospital have found.
By Bill Snyder
April 9, 2024

A history of race and health care leads April 18 Discovery Lecture

Vanessa Northington Gamble, MD, PhD, an internationally recognized advocate for equity and justice in American medicine and public health, will deliver the next Discovery Lecture at 4 p.m. Thursday, April 18, in 208 Light Hall.
By Bill Snyder
April 3, 2024

Excess salt linked to heart disease deaths in low-income group: study

Excessive consumption of dietary sodium likely was responsible for up to 30% of cardiovascular disease-related deaths among mostly low-income participants in a large cohort study conducted by Vanderbilt University Medical Center.
By Bill Snyder
April 2, 2024

VUMC research staff honored for excellence in the lab, clinic

Laboratory and administrative personnel at Vanderbilt University Medical Center were honored on March 29 for research excellence during the 20th annual Research Staff Awards Ceremony.
By Bill Snyder
April 1, 2024

Cell-specific variations in gene regulation may be key to treating pulmonary fibrosis

An international research team co-led by Vanderbilt University Medical Center has revealed how variations in gene regulation in different cell types drive pulmonary fibrosis, a progressive respiratory disorder characterized by scarring and loss of functional lung tissue.
By Bill Snyder
1 2 3 … 110